Metabolomic Analysis of Circulating Tumor Cells Derived Liver Metastasis of Colorectal Cancer

Overview

Journal Heliyon

Specialty Social Sciences

Date 2023 Jan 24

PMID 36691542

Authors

Meng Li

Shengming Wu

Chengle Zhuang

Chenzhang Shi

Lei Gu

Peng Wang

Fangfang Guo

Yilong Wang

Zhongchen Liu

Affiliations

Soon will be listed here.

Abstract

Metabolic reprogramming is one of the essential features of tumor that may dramatically contribute to metastasis and collapse. The metabolic profiling is investigated on the patient derived tissue and cancer cell line derived mouse metastasis xenograft. As well-recognized "seeds" for remote metastasis of tumor, role of circulating tumor cells (CTCs) in the study of metabolic reprogramming feature of tumor is yet to be elucidated. More specifically, whether there is difference of metabolic features of liver metastasis in colorectal cancer (CRC) derived from either CTCs or cancer cell line is still unknown. In this study, comprehensive untargeted metabolomics was performed using high performance liquid chromatography-mass spectrometry (HPLC-MS) in liver metastasis tissues from CT26 cells and CTCs derived mouse models. We identified 288 differential metabolites associated with the pathways such as one carbon pool by folate, folate biosynthesis and histidine metabolism through bioinformation analysis. Multiple gene expression was upregulated in the CTCs derived liver metastasis, specifically some specific enzymes. These results indicated that the metabolite phenotype and corresponding gene expression in the CTCs derived liver metastasis tissues was different from the parental CT26 cells, displaying a specific up-regulation of mRNAs involved in the above metabolism-related pathways. The metabolic profile of CTCs was characterized on the liver metastatic process in colorectal cancer. The invasion ability and chemo drug tolerance of the CTCs derived tumor and metastasis was found to be overwhelming higher than cell line derived counterpart. Identification of the differential metabolites will lead to a better understanding of the hallmarks of the cancer progression and metastasis, which may suggest potential attractive target for treating metastatic CRC.

Citing Articles

Liver Metastasis in Cancer: Molecular Mechanisms and Management.

Xu W, Xu J, Liu J, Wang N, Zhou L, Guo J MedComm (2020). 2025; 6(3):e70119.

PMID: 40027151 PMC: 11868442. DOI: 10.1002/mco2.70119.

Phenotypic diversity of CTCs and tdEVs in liquid biopsies of tumour-draining veins is linked to poor prognosis in colorectal cancer.

Cieslik S, Zafra A, Driemel C, Sudarsanam M, Cieslik J, Flugen G J Exp Clin Cancer Res. 2025; 44(1):9.

PMID: 39773651 PMC: 11708080. DOI: 10.1186/s13046-024-03259-6.

New insights into the correlations between circulating tumor cells and target organ metastasis.

Zhan Q, Liu B, Situ X, Luo Y, Fu T, Wang Y Signal Transduct Target Ther. 2023; 8(1):465.

PMID: 38129401 PMC: 10739776. DOI: 10.1038/s41392-023-01725-9.

A New Era of Integration between Multiomics and Spatio-Temporal Analysis for the Translation of EMT towards Clinical Applications in Cancer.

Fonseca Teixeira A, Wu S, Luwor R, Zhu H Cells. 2023; 12(23).

PMID: 38067168 PMC: 10706093. DOI: 10.3390/cells12232740.

Metabolomics analyses of cancer tissue from patients with colorectal cancer.

Kang C, Zhang J, Xue M, Li X, Ding D, Wang Y Mol Med Rep. 2023; 28(5).

PMID: 37772396 PMC: 10568249. DOI: 10.3892/mmr.2023.13106.

References

Newman A, Maddocks O . Serine and Functional Metabolites in Cancer. Trends Cell Biol. 2017; 27(9):645-657. DOI: 10.1016/j.tcb.2017.05.001. View

Yang H, Xu Y, Zhao X, Zou S, Zhang Y, Zhang M . Acetylation of MAT IIα represses tumour cell growth and is decreased in human hepatocellular cancer. Nat Commun. 2015; 6:6973. PMC: 4421817. DOI: 10.1038/ncomms7973. View

Agnoletto C, Corra F, Minotti L, Baldassari F, Crudele F, Cook W . Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset. Cancers (Basel). 2019; 11(4). PMC: 6521045. DOI: 10.3390/cancers11040483. View

Pollari S, Kakonen S, Edgren H, Wolf M, Kohonen P, Sara H . Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis. Breast Cancer Res Treat. 2010; 125(2):421-30. DOI: 10.1007/s10549-010-0848-5. View

Gkountela S, Castro-Giner F, Szczerba B, Vetter M, Landin J, Scherrer R . Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding. Cell. 2019; 176(1-2):98-112.e14. PMC: 6363966. DOI: 10.1016/j.cell.2018.11.046. View

Padmanaban V, Krol I, Suhail Y, Szczerba B, Aceto N, Bader J . E-cadherin is required for metastasis in multiple models of breast cancer. Nature. 2019; 573(7774):439-444. PMC: 7365572. DOI: 10.1038/s41586-019-1526-3. View

Newman A, Maddocks O . One-carbon metabolism in cancer. Br J Cancer. 2017; 116(12):1499-1504. PMC: 5518849. DOI: 10.1038/bjc.2017.118. View

Wu Z, Wei D, Gao W, Xu Y, Hu Z, Ma Z . TPO-Induced Metabolic Reprogramming Drives Liver Metastasis of Colorectal Cancer CD110+ Tumor-Initiating Cells. Cell Stem Cell. 2015; 17(1):47-59. DOI: 10.1016/j.stem.2015.05.016. View

Yang D, Yang X, Li Y, Zhao P, Fu R, Ren T . Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal. J Transl Med. 2020; 18(1):243. PMC: 7301449. DOI: 10.1186/s12967-020-02401-0. View

10.

Malara N, Trunzo V, Foresta U, Amodio N, De Vitis S, Roveda L . Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment. J Transl Med. 2016; 14(1):133. PMC: 4866436. DOI: 10.1186/s12967-016-0876-y. View

11.

Maddocks O, Berkers C, Mason S, Zheng L, Blyth K, Gottlieb E . Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature. 2012; 493(7433):542-6. PMC: 6485472. DOI: 10.1038/nature11743. View

12.

Ju H, Lu Y, Chen D, Zuo Z, Liu Z, Wu Q . Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications. J Natl Cancer Inst. 2018; 111(6):584-596. PMC: 6579745. DOI: 10.1093/jnci/djy160. View

13.

Pantel K, Speicher M . The biology of circulating tumor cells. Oncogene. 2015; 35(10):1216-24. DOI: 10.1038/onc.2015.192. View

14.

Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J . Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019; 567(7747):249-252. PMC: 6430113. DOI: 10.1038/s41586-019-1004-y. View

15.

Li Y, Bouza M, Wu C, Guo H, Huang D, Doron G . Sub-nanoliter metabolomics via mass spectrometry to characterize volume-limited samples. Nat Commun. 2020; 11(1):5625. PMC: 7648103. DOI: 10.1038/s41467-020-19444-y. View

16.

Abouleila Y, Onidani K, Ali A, Shoji H, Kawai T, Lim C . Live single cell mass spectrometry reveals cancer-specific metabolic profiles of circulating tumor cells. Cancer Sci. 2018; 110(2):697-706. PMC: 6361580. DOI: 10.1111/cas.13915. View

17.

Gujral T, Chan M, Peshkin L, Sorger P, Kirschner M, MacBeath G . A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis. Cell. 2014; 159(4):844-56. PMC: 4243058. DOI: 10.1016/j.cell.2014.10.032. View

18.

Maeshiro M, Shinriki S, Liu R, Nakachi Y, Komohara Y, Fujiwara Y . Colonization of distant organs by tumor cells generating circulating homotypic clusters adaptive to fluid shear stress. Sci Rep. 2021; 11(1):6150. PMC: 7969766. DOI: 10.1038/s41598-021-85743-z. View

19.

Eliasova P, Pinkas M, Kolostova K, Gurlich R, Bobek V . Circulating tumor cells in different stages of colorectal cancer. Folia Histochem Cytobiol. 2017; 55(1):1-5. DOI: 10.5603/FHC.a2017.0005. View

20.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View